Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPAC: Postoperative pain management with IONSYS (fentanyl ITS) in clinical practice
2008-002074-35Phase 4Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fentanyl iontophoretic transdermal system in postoperative pain, sponsored by Janssen Pharmaceutical. Primary endpoint: Use of intravenous line during fentanyl ITS treatment. Started May 2008; status: terminated.
02
Drugs
fentanyl iontophoretic transdermal system
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-002074-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002074-35.